EU indices slightly up this morning | TA focus on Bayer


European stocks report | Maersk | AstraZeneca | Bayer | EMS-Chemie...

Stocks (3)

Yesterday, European stocks returned to negative territory. The Stoxx Europe 600 Index fell 1.07%, Germany's DAX 30 dropped 1.14%, France's CAC 40 slid 1.33%, and the U.K.'s FTSE 100 was down 1.61%.

83% of STOXX 600 constituents traded lower or unchanged yesterday.
51% of the shares trade above their 20D MA vs 64% Wednesday (above the 20D moving average).
50% of the shares trade above their 200D MA vs 52% Wednesday (above the 20D moving average).

The Euro Stoxx 50 Volatility index added 2.05pts to 24.04, a new 52w high.

3mths relative high: Construction
3mths relative low: none

Europe Best 3 sectors
real estate, health care, media

Europe worst 3 sectors
basic resources, banks, financial services

The 10yr Bund yield fell 1bp to -0.47% (above its 20D MA). The 2yr-10yr yield spread rose 2bps to -18bps (above its 20D MA).

UK : UK-EU Brexit Talks
UK 07:00: Jul Retail Sales MoM, exp.: 13.9%
UK 07:00: Jul Retail Sales YoY, exp.: -1.6%
UK 07:00: Jul Retail Sales ex Fuel MoM, exp.: 13.5%
UK 07:00: Jul Retail Sales ex Fuel YoY, exp.: 1.7%
UK 07:00: Jul Public Sector Net Borrowing, exp.: £-34.8B
FR 08:15: Aug Markit Composite PMI Flash, exp.: 57.3
FR 08:15: Aug Markit Services PMI Flash, exp.: 57.3
FR 08:15: Aug Markit Manufacturing PMI Flash, exp.: 52.4
GE 08:30: Aug Markit Composite PMI Flash, exp.: 55.3
GE 08:30: Aug Markit Services PMI Flash, exp.: 55.6
GE 08:30: Aug Markit Manufacturing PMI Flash, exp.: 51
EC 09:00: Aug Markit Composite PMI Flash, exp.: 54.9
EC 09:00: Aug Markit Manufacturing PMI Flash, exp.: 51.8
EC 09:00: Aug Markit Services PMI Flash, exp.: 54.7
UK 09:30: Aug Markit/CIPS Manufacturing PMI Flash, exp.: 53.3
UK 09:30: Aug Markit/CIPS UK Services PMI Flash, exp.: 56.5
UK 09:30: Aug Markit/CIPS Composite PMI Flash, exp.: 57
EC 15:00: Aug Consumer Confidence Flash, exp.: -15

In Asian trading hours, EUR/USD edged up to 1.1877 and GBP/USD rose further to 1.3236. USD/JPY remains subdued at 105.66. AUD/USD advanced to 0.7204. Earlier today, official data showed that Australia's preliminary retail sales grew 3.3% on month in July (+2.7% in June).

Spot gold climbed to $1,950 an ounce.

AstraZeneca, a pharmaceutical giant, said its "Imfinzi (durvalumab) has been approved in Japan for the treatment of patients with extensive-stage small cell lung cancer".

Bayer, a pharmaceutical group, announced that it has agreed to pay 1.6 billion dollars to resolve 90% of about 39,000 total filed and unfiled U.S. Essure claims involving women who allege device-related injuries.

From a weekly point of view, the share remains within a descending channel since June 2017. Below the channel's upper boundary (set currently around 70E) look for the horizontal support of March 2020 at 44.85E and 32.15E in extension.

Source: GAIN Capital, TradingView

EMS-Chemie, a speciality chemicals company, announced that 1H net income declined 27.9% on year to 191 million Swiss franc and EBIT slid 28.2% to 227 million Swiss franc on net sales of 845 million Swiss franc, down 26.8%. Regarding the outlook, the company stated: "Based on the extraordinary market slump, EMS continues to expect net operating income (EBIT) for 2020 to be below previous year."

Maersk, a Danish integrated shipping company, was downgraded to "neutral" from "overweight" at JPMorgan.

Sampo, a Finnish financial company, was upgraded to "overweight" from "equalweight" at Morgan Stanley.

More from Equities

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.